SK Bioscience gets info security management system certification

The company secures ISO 27001 certification according to EU's GDPR guidelines

SK Bioscience gets info security management system certification
Jung-Eun Kim 1
2023-02-07 15:04:42 likesmile@hankyung.com
Bio & Pharma

SK Bioscience Co. said on Tuesday that its Pangyo headquarters and its vaccine production facility L House in Andong, South Korea, have acquired ISO 27001, an international standard for information security management systems.

ISO 27001 can only be obtained after an evaluation of physical and environmental security and network security conducted by the International Organization for Standardization.

The company explained that it prepared for the certification evaluation according to the guidelines of the European Union's general data protection regulation (GDPR).

"We are continuously striving to strengthen our global competitiveness and enhance the reliability of our global partners through the successive acquisition of international standard certifications," said Ahn Jae-yong, CEO of SK Bioscience.

Write to Jung-Eun Kim at likesmile@hankyung.com

SK Bioscience climbs two notches in ESG evaluation, receives BBB rating

SK Bioscience climbs two notches in ESG evaluation, receives BBB rating

SK Bioscience Co., a biopharmaceutical arm of South Korea's SK Group, announced it has received a BBB rating in its latest environmental, social, and governance (ESG) evaluation from Morgan Stanley Capital International (MSCI).The 2022 evaluation saw the firm improve two steps from its previou

SK Bioscience's SKYCellflu approved by Chilean health authority

SK Bioscience's SKYCellflu approved by Chilean health authority

SK Bioscience's SKYCellflu SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, announced on Thursday that its world-first cell culture-based quadrivalent influenza vaccine SKYCellflu has received approval from the Instituto de Salud Publica de Chile (Chilean Institu

SK Bioscience's shingles vaccine obtains product approval from Malaysia

SK Bioscience's shingles vaccine obtains product approval from Malaysia

SK Bioscience's Sky Zoster SK Bioscience Co. said on Monday that its shingles vaccine Sky Zoster has been given approval by Malaysia's National Pharmaceutical Regulatory Agency.Sky Zoster is a live attenuated vaccine developed by SK Bioscience with its proprietary technology and was approved

SK Bioscience seeks WHO nod for prompt COVID vaccine sale

SK Bioscience seeks WHO nod for prompt COVID vaccine sale

SK Bioscience’s production line of SKYCovione in South Korea (Courtesy of Yonhap) SK Bioscience Co., the biopharmaceutical unit of South Korea’s No. 2 conglomerate SK Group, sought approval from the World Health Organization (WHO) for the immediate sale of the company’s COVID-

(* comment hide *}